John L Higgins is Director of LIGAND PHARMACEUTICALS INC. Currently has a direct ownership of 417,695 shares of LGND, which is worth approximately $43.5 Million. The most recent transaction as insider was on Dec 28, 2022, when has been sold 5,289 shares (Common Stock) at a price of $66.29 per share, resulting in proceeds of $350,607. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 418K
0% 3M change
0% 12M change
Total Value Held $43.5 Million

JOHN L HIGGINS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 28 2022
SELL
Payment of exercise price or tax liability
$350,607 $66.29 p/Share
5,289 Reduced 1.25%
417,695 Common Stock
Dec 16 2022
SELL
Open market or private sale
$618,700 $61.87 p/Share
10,000 Reduced 2.31%
422,984 Common Stock
Dec 12 2022
SELL
Sale (or disposition) back to the issuer
$255,571 $64.8 p/Share
3,944 Reduced 0.9%
432,984 Common Stock
Dec 12 2022
BUY
Exercise of conversion of derivative security
$255,600 $12.78 p/Share
20,000 Added 4.38%
436,928 Common Stock
Nov 30 2022
SELL
Payment of exercise price or tax liability
$714,638 $72.9 p/Share
9,803 Reduced 2.3%
416,928 Common Stock
Nov 18 2022
BUY
Exercise of conversion of derivative security
$127,800 $12.78 p/Share
10,000 Added 2.29%
426,731 Common Stock
Nov 17 2022
SELL
Open market or private sale
$783,199 $78.32 p/Share
10,000 Reduced 2.34%
416,731 Common Stock
Nov 01 2022
BUY
Grant, award, or other acquisition
-
45,922 Added 9.76%
424,731 Common Stock
Sep 16 2022
SELL
Open market or private sale
$268,050 $89.35 p/Share
3,000 Reduced 0.82%
364,180 Common Stock
Sep 15 2022
SELL
Open market or private sale
$180,000 $90.0 p/Share
2,000 Reduced 0.54%
367,180 Common Stock
Jun 30 2022
BUY
Other acquisition or disposition
$12,438 $75.84 p/Share
164 Added 0.04%
369,180 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
20,423 Added 5.24%
369,016 Common Stock
May 09 2022
BUY
Exercise of conversion of derivative security
$175,360 $21.92 p/Share
8,000 Added 2.24%
348,593 Common Stock
Feb 15 2022
SELL
Payment of exercise price or tax liability
$732,557 $123.68 p/Share
5,923 Reduced 1.71%
340,593 Common Stock
Jan 26 2022
SELL
Payment of exercise price or tax liability
$1,050,744 $113.68 p/Share
9,243 Reduced 2.58%
349,018 Common Stock
Jan 26 2022
BUY
Grant, award, or other acquisition
-
23,166 Added 6.07%
358,261 Common Stock
Nov 12 2021
SELL
Open market or private sale
$481,500 $160.5 p/Share
3,000 Reduced 0.89%
335,095 Common Stock
Jun 30 2021
BUY
Other acquisition or disposition
$21,220 $85.91 p/Share
247 Added 0.07%
338,095 Common Stock
Feb 15 2021
SELL
Payment of exercise price or tax liability
$898,862 $172.46 p/Share
5,212 Reduced 1.52%
337,848 Common Stock
Feb 05 2021
SELL
Payment of exercise price or tax liability
$602,999 $203.03 p/Share
2,970 Reduced 0.86%
343,060 Common Stock
Feb 05 2021
SELL
Open market or private sale
$11,119,064 $203.4 p/Share
54,666 Reduced 16.05%
286,030 Common Stock
Feb 05 2021
BUY
Exercise of conversion of derivative security
$1,405,805 $12.26 p/Share
114,666 Added 24.89%
346,030 Common Stock
Feb 03 2021
BUY
Grant, award, or other acquisition
-
12,608 Added 4.22%
286,030 Common Stock
Jan 27 2021
SELL
Open market or private sale
$7,280,000 $182.0 p/Share
40,000 Reduced 14.11%
243,422 Common Stock
Jan 27 2021
BUY
Exercise of conversion of derivative security
$1,274,000 $18.2 p/Share
70,000 Added 20.38%
273,422 Common Stock

Also insider at

TECH
BIO-TECHNE Corp Healthcare
AHPAW
Avista Public Acquisition Corp. II Financial Services
JLH

John L Higgins

Director
Emeryville, CA

Track Institutional and Insider Activities on LGND

Follow LIGAND PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LGND shares.

Notify only if

Insider Trading

Get notified when an Ligand Pharmaceuticals Inc insider buys or sells LGND shares.

Notify only if

News

Receive news related to LIGAND PHARMACEUTICALS INC

Track Activities on LGND